Compare Danaher Corporation (DHR) vs GE Aerospace (GE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaher Corporation vs GE Aerospace — how do they compare? Danaher Corporation trades at $201.23 (market cap $140.88B), while GE Aerospace trades at $355.79 (market cap $369.06B). The key difference: GE Aerospace is far larger — about 2.6× Danaher Corporation's market cap, and Danaher Corporation pays the higher dividend (0.8%). Which is the better fit depends on your goals.
| DHR | GE | |
|---|---|---|
Market Cap | $140.88B | $369.06B |
Sector | Health | Industrials |
52-Week High | $242.05 | $378.68 |
52-Week Low | $161.91 | $259.00 |
Enterprise Value | $153.66B | $378.36B |
Dividend Yield | 0.8% | 0.53% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $200.16, up 0.56% today, with a bullish technical signal from moving averages and strong analyst support. The company reported Q1 2026 EPS of $2.06, beating estimates of $1.94, marking the third consecutive quarterly beat. Revenue for 2025 was $24.57 billion with a net income margin of 14.89%, though margins have compressed from prior years. Recent news includes the acquisition of Masimo and a $172.5 million legal settlement finalized in April 2026.
The outlook remains positive with a consensus price target of $211.33, implying ~5.6% upside, supported by 69% buy ratings. Key risks include margin pressure, integration challenges from acquisitions, and macroeconomic sensitivity. The stock offers a dividend yield from its $0.40 quarterly payout, with solid cash flow generation offsetting debt levels.
GE trades at $353.42, down 1.63% on the day, with a bullish technical signal supported by moving averages and oversold RSI levels near support at $351. The company has beaten earnings estimates for three consecutive quarters, with Q1 2026 EPS of $1.86 exceeding expectations, while revenue grew to $45.86 billion in 2025. Analyst sentiment is strongly positive with a consensus buy rating and $397 price target, driven by robust aerospace demand and recent defense contract wins.
The outlook remains favorable given strong order growth and strategic investments, but risks include high valuation multiples (P/E of 43.94) and debt levels. Upside is supported by earnings momentum and institutional confidence, though investors should monitor execution on backlog conversion and macroeconomic pressures on the aerospace sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →About GE Aerospace
General Electric Company is a globally diversified technology and financial services company. The Company's products and services include aircraft engines, power generation, water processing, and household appliances to medical imaging, business and consumer financing, and industrial products.
Read more on GE →
